Last quarter (Q4 2023), Fulgent Genetics's total revenue was $70.50M, an increase of 4.14% from the same quarter last year. In Q4, Fulgent Genetics's net income was $-128.15M. See Fulgent Genetics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 289.21M	$ 289.21M	$ 618.97M	$ 992.58M	$ 421.71M	$ 32.53M
Cost of Revenue	$ 184.76M	$ 184.76M	$ 252.07M	$ 215.53M	$ 89.81M	$ 14.11M
Gross Profit	$ 104.46M	$ 104.46M	$ 366.90M	$ 777.05M	$ 331.90M	$ 18.42M
Operating Expense	$ 299.99M	$ 299.99M	$ 188.37M	$ 101.10M	$ 41.75M	$ 18.85M
Operating Income	$ -195.53M	$ -195.53M	$ 178.53M	$ 675.95M	$ 290.16M	$ -428.00K
Net Non Operating Interest Income Expense	$ 21.44M	$ 21.44M	$ 5.50M	$ 1.35M	$ 1.53M	$ 837.00K
Other Income Expense	$ 4.80M	$ 4.80M	$ 252.07M	$ -28.90M	-	-
Pretax Income	$ -174.09M	$ -174.09M	$ 184.03M	$ 677.30M	$ 291.68M	$ 409.00K
Tax Provision	$ 1.15M	$ 1.15M	$ 42.10M	$ 174.79M	$ 72.53M	$ 43.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	$ -4.84M	$ -777.00K
Net Income Common Stockholders	$ -167.80M	$ -167.82M	$ 143.40M	$ 507.36M	$ 214.31M	$ -411.00K
Basic EPS	$ -5.64	$ -5.63	$ 4.76	$ 17.25	$ 9.44	$ -0.02
Diluted EPS	$ -5.64	$ -5.63	$ 4.63	$ 16.38	$ 8.91	$ -0.02
Basic Average Shares	$ 119.14M	$ 29.78M	$ 30.10M	$ 29.41M	$ 22.69M	$ 18.71M
Diluted Average Shares	$ 119.14M	$ 29.78M	$ 30.96M	$ 30.98M	$ 24.06M	$ 18.71M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	$ 9.65	$ 0.19
Reported Normalized Diluted E P S	-	-	-	-	$ 9.10	$ 0.19
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 484.74M	$ 484.74M	$ 440.44M	$ 316.63M	$ 131.55M	$ 32.96M
Net Income From Continuing And Discontinued Operation	$ -168.33M	$ -167.82M	$ 143.40M	$ 507.36M	$ 214.31M	$ -411.00K
Normalized Income	$ -33.09M	$ -2.19M	$ 400.42M	-	$ 214.31M	$ -411.00K
Interest Expense	-	-	-	-	-	-
EBIT	$ -174.41M	$ -174.00M	$ 184.37M	$ 677.18M	$ 290.16M	$ -428.00K
EBITDA	$ -148.26M	$ -147.86M	$ 221.80M	$ 695.78M	$ 293.12M	$ 1.68M

Currency in USD

Fulgent Genetics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing